{"id":7031,"date":"2020-05-21T16:10:10","date_gmt":"2020-05-21T23:10:10","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=7031"},"modified":"2021-03-19T16:10:52","modified_gmt":"2021-03-19T23:10:52","slug":"similar-incidence-of-coronavirus-disease-2019-covid-19-in-patients-with-rheumatic-diseases-with-and-without-hydroxychloroquine-therapy","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/05\/21\/similar-incidence-of-coronavirus-disease-2019-covid-19-in-patients-with-rheumatic-diseases-with-and-without-hydroxychloroquine-therapy\/","title":{"rendered":"Similar Incidence of Coronavirus Disease 2019 (COVID-19) in Patients with Rheumatic Diseases with and without\u00a0Hydroxychloroquine\u00a0Therapy"},"content":{"rendered":"<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"34\" data-aria-posinset=\"1\" data-aria-level=\"1\"><i><span data-contrast=\"none\">[<\/span><\/i><i><span data-contrast=\"none\">pre-print, not peer reviewed<\/span><\/i><i><span data-contrast=\"none\">]<\/span><\/i><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">Macias et al. conducted a\u00a0<\/span><span data-contrast=\"auto\">retrospective analysis of 722 patients with autoimmune rheumatic diseases\u00a0<\/span><span data-contrast=\"auto\">who were being\u00a0<\/span><span data-contrast=\"auto\">treated with<\/span><span data-contrast=\"auto\">\u00a0(n=423)<\/span><span data-contrast=\"auto\">\u00a0and without\u00a0<\/span><span data-contrast=\"auto\">hydroxychloroquine<\/span><span data-contrast=\"auto\">\u00a0(<\/span><span data-contrast=\"auto\">n=<\/span><span data-contrast=\"auto\">290) in Seville, Spain<\/span><span data-contrast=\"auto\">.\u00a0<\/span><span data-contrast=\"auto\">I<\/span><span data-contrast=\"auto\">ncidence and severity of COVID-19\u00a0<\/span><span data-contrast=\"auto\">did not differ between the treatment groups.\u00a0<\/span><span data-contrast=\"auto\">Over seven\u00a0<\/span><span data-contrast=\"auto\">week<\/span><span data-contrast=\"auto\">s<\/span><span data-contrast=\"auto\">, 5 (1.7%) cases of COVID-19 were reported among patients using\u00a0<\/span><span data-contrast=\"auto\">hydroxychloroquine<\/span><span data-contrast=\"auto\">\u00a0and 5 (1.2%) among\u00a0<\/span><span data-contrast=\"auto\">those<\/span><span data-contrast=\"auto\">\u00a0without\u00a0<\/span><span data-contrast=\"auto\">hydroxychloroquine<\/span><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><i><span data-contrast=\"none\">Macias et al. (May 20, 2020). Similar Incidence of Coronavirus Disease 2019 (COVID-19) in Patients with Rheumatic Diseases with and without\u00a0<\/span><\/i><i><span data-contrast=\"none\">Hydroxychloroquine<\/span><\/i><i><span data-contrast=\"none\">\u00a0Therapy. Pre-print downloaded May 21 from\u00a0<\/span><\/i><a href=\"https:\/\/doi.org\/10.1101\/2020.05.16.20104141\"><span data-contrast=\"none\">https:\/\/doi.org\/10.1101\/2020.05.16.20104141<\/span><\/a><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559685&quot;:720,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[pre-print, not peer reviewed]\u00a0Macias et al. conducted a\u00a0retrospective analysis of 722 patients with autoimmune rheumatic diseases\u00a0who were being\u00a0treated with\u00a0(n=423)\u00a0and without\u00a0hydroxychloroquine\u00a0(n=290) in Seville, Spain.\u00a0Incidence and severity of COVID-19\u00a0did not differ between the treatment groups.\u00a0Over seven\u00a0weeks, 5 (1.7%) cases of COVID-19 were reported among patients using\u00a0hydroxychloroquine\u00a0and 5 (1.2%) among\u00a0those\u00a0without\u00a0hydroxychloroquine.\u00a0 Macias et al. (May 20, 2020). Similar Incidence&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/05\/21\/similar-incidence-of-coronavirus-disease-2019-covid-19-in-patients-with-rheumatic-diseases-with-and-without-hydroxychloroquine-therapy\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"topic":[19],"class_list":["post-7031","post","type-post","status-publish","format-standard","hentry","category-article-summary","topic-testing-and-treatment"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/7031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=7031"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/7031\/revisions"}],"predecessor-version":[{"id":7032,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/7031\/revisions\/7032"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=7031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=7031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=7031"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=7031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}